Cargando…
An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China
The Omicron variants spread rapidly worldwide after being initially detected in South Africa in November 2021. It showed increased transmissibility and immune evasion with far more amino acid mutations in the spike (S) protein than the previously circulating variants of concern (VOCs). Notably, on 1...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Medical Association (CMA) Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613801/ https://www.ncbi.nlm.nih.gov/pubmed/36320663 http://dx.doi.org/10.1016/j.bsheal.2022.10.003 |
_version_ | 1784820053329313792 |
---|---|
author | Zhang, Meiling Chen, Zhixiao Zhou, Jienan Zhao, Xiaonan Chen, Yaoyao Sun, Yanhong Liu, Zhaosheng Gu, Wenpeng Luo, Chunrui Fu, Xiaoqing Zhao, Xiang |
author_facet | Zhang, Meiling Chen, Zhixiao Zhou, Jienan Zhao, Xiaonan Chen, Yaoyao Sun, Yanhong Liu, Zhaosheng Gu, Wenpeng Luo, Chunrui Fu, Xiaoqing Zhao, Xiang |
author_sort | Zhang, Meiling |
collection | PubMed |
description | The Omicron variants spread rapidly worldwide after being initially detected in South Africa in November 2021. It showed increased transmissibility and immune evasion with far more amino acid mutations in the spike (S) protein than the previously circulating variants of concern (VOCs). Notably, on 15 July 2022, we monitored the first VOC / Omicron subvariant BA.2.75 in China from an imported case. Moreover, nowadays, this subvariant still is predominant in India. It has nine additional mutations in the S protein compared to BA.2, three of which (W152R, G446S, and R493Q reversion) might contribute to higher transmissibility and immune escape. This subvariant could cause wider spread and pose a threat to the global situation. Our timely reporting and continuous genomic analysis are essential to fully elucidate the characteristics of the subvariant BA.2.75 in the future. |
format | Online Article Text |
id | pubmed-9613801 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Chinese Medical Association (CMA) Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96138012022-10-28 An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China Zhang, Meiling Chen, Zhixiao Zhou, Jienan Zhao, Xiaonan Chen, Yaoyao Sun, Yanhong Liu, Zhaosheng Gu, Wenpeng Luo, Chunrui Fu, Xiaoqing Zhao, Xiang Biosaf Health Article The Omicron variants spread rapidly worldwide after being initially detected in South Africa in November 2021. It showed increased transmissibility and immune evasion with far more amino acid mutations in the spike (S) protein than the previously circulating variants of concern (VOCs). Notably, on 15 July 2022, we monitored the first VOC / Omicron subvariant BA.2.75 in China from an imported case. Moreover, nowadays, this subvariant still is predominant in India. It has nine additional mutations in the S protein compared to BA.2, three of which (W152R, G446S, and R493Q reversion) might contribute to higher transmissibility and immune escape. This subvariant could cause wider spread and pose a threat to the global situation. Our timely reporting and continuous genomic analysis are essential to fully elucidate the characteristics of the subvariant BA.2.75 in the future. Chinese Medical Association (CMA) Published by Elsevier B.V. 2022-12 2022-10-28 /pmc/articles/PMC9613801/ /pubmed/36320663 http://dx.doi.org/10.1016/j.bsheal.2022.10.003 Text en © 2022 Chinese Medical Association (CMA) Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Zhang, Meiling Chen, Zhixiao Zhou, Jienan Zhao, Xiaonan Chen, Yaoyao Sun, Yanhong Liu, Zhaosheng Gu, Wenpeng Luo, Chunrui Fu, Xiaoqing Zhao, Xiang An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China |
title | An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China |
title_full | An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China |
title_fullStr | An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China |
title_full_unstemmed | An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China |
title_short | An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China |
title_sort | imported human case with the sars-cov-2 omicron subvariant ba.2.75 in yunnan province, china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613801/ https://www.ncbi.nlm.nih.gov/pubmed/36320663 http://dx.doi.org/10.1016/j.bsheal.2022.10.003 |
work_keys_str_mv | AT zhangmeiling animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT chenzhixiao animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT zhoujienan animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT zhaoxiaonan animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT chenyaoyao animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT sunyanhong animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT liuzhaosheng animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT guwenpeng animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT luochunrui animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT fuxiaoqing animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT zhaoxiang animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT zhangmeiling importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT chenzhixiao importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT zhoujienan importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT zhaoxiaonan importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT chenyaoyao importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT sunyanhong importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT liuzhaosheng importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT guwenpeng importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT luochunrui importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT fuxiaoqing importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina AT zhaoxiang importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina |